There was a strongassociation of SSc-AAV and pulmonary emboli, particularly in anti-PR3+ patients.The increased prevalence of ILD in SSc-AAV compared to SSc alone is postulatedto be secondary to subclinical vasculopathy. This evidence concerns the gene PRTN3 and interstitial lung disease.